Regarding amendments to the instructions for medical use of medicinal products containing Etanercept, Golimumab, Infliximab
26.02.2019
2683
Dear applicants! The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (PRAC EMA), having reviewed the available evidence from the reviews provided by holders…
Read more